Veterinary Research Forum
Vet Res Forum

Protective effect of quercetin liposome on acute low dose diazinon-induced oxidative stress and neurobehavioral disorders by affecting serotonin metabolite in mature male rats

Document Type : Original Article

Authors

Beheshteh Babazadeh 1, 2
Homeira Hatami Nemati 2
Nasser Aslani 3
Gholamreza Dehghan 2
Sama Radbin 2
Valida Madatova 1

1 Department of Zoology and Physiology, Faculty of Biology, Baku State University, Baku, Azerbaijan

2 Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran

3 Research Laboratory of Polymer and Nanomaterial, Faculty of Chemistry, University of Tabriz, Tabriz, Iran

https://doi.org/10.30466/vrf.2024.2032844.4326
Abstract
Diazinon (DZN) is a widely used organophosphate. We studied the effect of quercetin pegylated liposome (QPEGL) on acute low dose DZN-induced oxidative stress and behavioral disorders through monitoring brain serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA) in mature male rats. Animals were treated in two control groups that received a single dose of normal saline and dimethyl sulfoxide, and four groups that received a single dose of DZN 10.00 mg kg-1 (DZN), DZN 10.00 mg kg + quercetin 20.00 mg kg-1, DZN 10.00 mg kg-1 + PEGL 20.00 mg kg-1, DZN 10.00 mg kg-1 + QPEGL 20.00 mg kg-1 (QPEGL), respectively. Performances of the rats were investigated by the open field and elevated plus maze tests. Twenty-four hr after the treatments, animals’ brains were harvested and frozen at – 80.00 ˚C. Brain tissues 5-HIAA level was determined by the enzyme-linked immunosorbent assay. Furthermore, malondialdehyde (MDA), superoxide dismutase (SOD), and glutathione peroxidase (GPx) levels were determined for oxidative stress analysis. The motor activity was significantly reduced in the DZN group compared to the control group following increased anxiety-like behavior and ameliorated by QPEGL. Moreover, 5-HIAA and MDA levels notably increased in the DZN group compared to the control group and significantly decreased in the QPEGL group compared to the DZN group. The SOD and GPx contents were not significantly changed in the DZN group compared to the control; although, these parameters improved after treatment with QPEGL. Acute low dose DZN exposure resulted in lipid peroxidation and elevated levels of the serotonin metabolite (5-HIAA), leading to neurobehavioral disorders, such as anxiety-like behavior and impaired motor activity, which were alleviated by QPEGL.

Keywords

Anxiety
Diazinon
Liposome
Oxidative stress
Quercetin

Subjects

  1. Moser VC, Simmons JE, Gennings C. Neurotoxicological interactions of a five-pesticide mixture in preweanling rats. Toxicol Sci 2006; 92(1): 235-245.
  2. Koh SB, Kim TH, Min S, et al. Exposure to pesticide as a risk factor for depression: a population-based longitudinal study in Korea. Neurotoxicology 2017; 62: 181-185.
  3. Mackenzie Ross SJ, Brewin CR, Curran HV, et al. Neuro-psychological and psychiatric functioning in sheep farmers exposed to low levels of organophosphate pesticides. Neurotoxicol Teratol 2010; 32(4): 452-459.
  4. Lari P, Abnous K, Imenshahidi M, et al. Evaluation of diazinon-induced hepatotoxicity and protective effects of crocin. Toxicol Ind Health 2015; 31(4): 367-376.
  5. Messarah M, Amamra W, Boumendjel A, et al. Ameliorating effects of curcumin and vitamin E on diazinon-induced oxidative damage in rat liver and erythrocytes. Toxicol Ind Health 2013; 29(1): 77-88.
  6. Harchegani AB, Rahmani A, Tahmasbpour E, et al. Mechanisms of diazinon effects on impaired spermatogenesis and male infertility. Toxicol Ind Health 2018; 34(9): 653-664.
  7. Jayamohananan H, Manoj Kumar MK, T P A. 5-HIAA as a potential biological marker for neurological and psychiatric disorders. Adv Pharm Bull 2019; 9(3): 374-381.
  8. Lang W, Masucci JA, Caldwell GW, et al. Liquid chromatographic and tandem mass spectrometric assay for evaluation of in vivo inhibition of rat brain monoamine oxidases (MAO) A and B following a single dose of MAO inhibitors: application of biomarkers in drug discovery. Anal Biochem 2004; 333(1): 79-87.
  9. Chocron O, Aybek S, Paraschiv-Ionescu A, et al. Measuring real life motor activity in depression. J Transl Sci 2020; 7: 1-4. doi: 10.15761/JTS.1000412.
  10. Judge SJ, Savy CY, Campbell M, et al. Mechanism for the acute effects of organophosphate pesticides on the adult 5-HT system. Chem Boil Interact 2016; 245: 82-89.
  11. Savy CY, Fitchett AE, McQuade R, et al. Low-level repeated exposure to diazinon and chlorpyrifos decrease anxiety-like behaviour in adult male rats as assessed by marble burying behaviour. Neuro-toxicology 2015; 50: 149-156.
  12. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 1983; 32(7): 1141-1148.
  13. Chakraborty J, Singh R, Dutta D, et al. Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in 3‐nitropropionic acid‐induced rat model of Huntington's disease. CNS Neurosci Ther 2014; 20(1): 10-19.
  14. Choi EJ, Chee KM, Lee BH. Anti- and prooxidant effects of chronic quercetin administration in rats. Eur J Pharmacol 2003; 482(1-3): 281-285.
  15. Abbas MT. The protective effect of quercetin on diazinon-induced oxidative stress in rats. Irq Nat J Chem 2014; 14(53): 96-122.
  16. Ganesan P, Ko HM, Kim IS, et al. Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson’s disease models. Int J Nanomedicine 2015; 10: 6757-6772.
  17. Ghosh A, Sarkar S, Mandal AK, et al. Neuroprotective role of nanoencapsulated quercetin in combating ischemia-reperfusion induced neuronal damage in young and aged rats. PLoS One 2013; 8(4): e57735. doi: 10.1371/journal.pone.0057735.
  18. Amanzadeh E, Esmaeili A, Rahgozar S, et al. Application of quercetin in neurological disorders: from nutrition to nanomedicine. Rev Neurosci 2019; 30(5): 555-572.
  19. Liu H, Xue JX, Li X, et al. Quercetin liposomes protect against radiation‑induced pulmonary injury in a murine model. Oncol let 2013; 6(2): 453-459.
  20. Sun W, Zhang N, Li A, et al. Preparation and evaluation of N3-O-toluyl-fluorouracil-loaded liposomes. Int J Pharm 2008; 353(1-2): 243-250.
  21. Li J, Li Z, Gao Y, et al. Effect of a drug delivery system made of quercetin formulated into PEGylation liposomes on cervical carcinoma in vitro and in vivo. J Nanomater 2021; 2021(1): 9389934. doi: 10.1155/ 2021/9389934.
  22. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
  23. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70(1): 158-169.
  24. Paoletti F, Aldinucci D, Mocali A, et al. A sensitive spectrophotometric method for the determination of superoxide dismutase activity in tissue extracts. Anal Biochem 1986; 154(2): 536-541.
  25. Rodríguez-Fuentes G, Rubio-Escalante FJ, Noreña-Barroso E, et al. Impacts of oxidative stress on acetylcholinesterase transcription, and activity in embryos of zebrafish (Danio rerio) following Chlorpyrifos exposure. Comp Biochem Physiol Part C Toxicol Pharmacol 2015; 172-173: 19-25.
  26. Yilmaz N, Yilmaz M, Altuntas I. Diazinon-induced brain toxicity and protection by vitamins E plus C. Toxicol Ind Health 2012; 28(1): 51-57.
  27. Abdou HM, ElMazoudy RH. Oxidative damage, hyperlipidemia and histological alterations of cardiac and skeletal muscles induced by different doses of diazinon in female rats. J Hazard Mater 2010; 182(1-3): 273-278.
  28. Roegge CS, Timofeeva OA, Seidler FJ, et al. Developmental diazinon neurotoxicity in rats: later effects on emotional response. Brain Res Bull 2008; 75(1): 166-172.
  29. Dhaouadi Z, Nsangou M, Garrab N, et al. DFT study of the reaction of quercetin with· O-2 and·OH radicals. J Mol Struct THEOCHEM 2009; 904(1-3): 35-42.
  30. Oyama Y, Fuchs PA, Katayama N, et al. Myricetin and quercetin, the flavonoid constituents of Ginkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca(2+)-loaded brain neurons. Brain Res 1994; 635(1-2): 125-129.
  31. Naidu PS, Singh A, Kulkarni SK. Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia. Neuropharmacology 2003; 44(8): 1100-1106.
  32. Lu J, Zheng YL, Luo L, et al. Quercetin reverses D-galactose induced neurotoxicity in mouse brain. Behav Brain Res 2006; 171(2): 251-260.
  33. Molaei A, Hatami H, Dehghan G, et al. Synergistic effects of quercetin and regular exercise on the recovery of spatial memory and reduction of parameters of oxidative stress in animal model of Alzheimer's disease. EXCLI J 2020; 19: 596-612.
  34. Dhiman P, Malik N, Sobarzo-Sánchez E, et al. Quercetin and related chromenone derivatives as monoamine oxidase inhibitors: targeting neurological and mental disorders. Molecules 2019; 24(3): 418. doi: 10.3390/ molecules24030418.
  35. Cheng KK, Yeung CF, Ho SW, et al. Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer’s disease Tg2576 mice. AAPS J 2013; 15(2): 324-336.
  36. Tang L, Li K, Zhang Y, et al. Quercetin liposomes ameliorate streptozotocin-induced diabetic nephron-pathy in diabetic rats. Sci Rep 2020; 10: 2440. doi: 10.1038/s41598-020-59411-7.
Veterinary Research Forum
Volume 16, Issue 7
July 2025
Pages 399-406

  • Receive Date 18 June 2024
  • Revise Date 22 September 2024
  • Accept Date 05 October 2024

Home

Guide for Authors

Submit Manuscript

Reviewers

Contact Us